Phathom Pharmaceuticals, Inc. — Director's Dealing 2022

May 20, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2022-05-19

Reporting Person: Curran Terrie (Director, President and Chief Executive)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-19	Common Stock	A	12000	$0.00	Acquired	76595	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	724.1	Indirect

Footnotes

F1: Represents restricted stock units ("RSUs") granted on May 19, 2022. One third (1/3) of the total number of RSUs granted vest on November 19, 2022, May 19, 2023 and November 19, 2023, subject to the Reporting Person's continued service on each applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.